Plasminogen Activator Inhibitor-1 in Chronic Kidney Disease
Open Access
- 1 November 2006
- journal article
- review article
- Published by Wolters Kluwer Health in Journal of the American Society of Nephrology
- Vol. 17 (11), 2999-3012
- https://doi.org/10.1681/asn.2006050503
Abstract
No abstract availableThis publication has 103 references indexed in Scilit:
- Endocytic receptor LRP together with tPA and PAI-1 coordinates Mac-1-dependent macrophage migrationThe EMBO Journal, 2006
- Multifunctionality of PAI-1 in fibrogenesis: Evidence from obstructive nephropathy in PAI-1–overexpressing miceKidney International, 2005
- Combining TGF-β inhibition and angiotensin II blockade results in enhanced antifibrotic effectKidney International, 2004
- Spironolactone prevents early renal injury in streptozotocin-induced diabetic ratsKidney International, 2004
- Bradykinin Decreases Plasminogen Activator Inhibitor-1 Expression and Facilitates Matrix Degradation in the Renal Tubulointerstitium under Angiotensin-Converting Enzyme BlockadeJournal of the American Society of Nephrology, 2004
- Plasmin is not protective in experimental renal interstitial fibrosis1Kidney International, 2004
- Expression of urokinase plasminogen activator and its receptor during acute renal allograft rejectionKidney International, 2003
- Inhibition of Angiogenesis in Vivo by Plasminogen Activator Inhibitor-1Journal of Biological Chemistry, 2001
- Does urokinase play a role in renal stone formation?Medical Hypotheses, 1997
- Glomerular fibrinolytic activity in anti-GBM glomerulonephritis in rabbitsKidney International, 1993